Extraosseous Ameloblastoma: A Rare Tumor of the Gingiva
Extraosseous ameloblastoma is a unique type of tumor that develops on the gingiva, which is the fibrous tissue that supports and holds the teeth in place. Unlike other types of ameloblastoma that involve the jawbone, extraosseous ameloblastoma appears as smooth, raised nodules on the gum tissue. Although rare, accounting for only 1 to 2 percent of all cases, it is important to address this condition promptly.
Due to the absence of bone involvement in extraosseous ameloblastoma, surgical excision is considered the most effective treatment option. By completely removing the tumor, the risk of recurrence is minimized. It is worth noting that the maximum recurrence rate for this type of ameloblastoma is approximately 10 percent.
Gorlin-Goltz Syndrome: A Genetic Mutation Leading to Bone Defects
Gorlin-Goltz Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome (NBCCS), is a genetic condition caused by a mutation in a specific gene. This syndrome affects multiple systems in the body, including the bones. One of the notable effects of Gorlin-Goltz Syndrome is the development of frequent jaw cysts, with less frequent occurrences of ameloblastomas.
A comprehensive twenty-year study has revealed a significant correlation between basal cell carcinomas and the occurrence of odontogenic tumors in individuals with Gorlin-Goltz Syndrome. This finding has prompted doctors to investigate the possibility of using ameloblastomas as a criterion for identifying individuals who may be at risk of developing NBCCS.